Your browser doesn't support javascript.
loading
A Novel Mutation Diagnosing in Allan-Herndon-Dudley's Syndrome.
Ipek, Rojan; Bozdogan, Sevcan Tug; Kömür, Mustafa; Okuyaz, Cetin.
Afiliação
  • Ipek R; Department of Pediatrics, Division of Neurology, Training and Research Hospital, Adiyaman University, Adiyaman, Turkey.
  • Bozdogan ST; Department of Medical Genetics, Medical Faculty, Çukurova University, Adana, Turkey.
  • Kömür M; Department of Pediatrics, Division of Neurology, Medical Faculty, Mersin University, Mersin, Turkey.
  • Okuyaz C; Department of Pediatrics, Division of Neurology, Medical Faculty, Mersin University, Mersin, Turkey.
J Pediatr Genet ; 13(2): 144-148, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38721571
ABSTRACT
Allan-Herndon-Dudley's syndrome (AHDS) is a rare X-linked recessive disease that causes abnormal serum thyroid function tests, severe hypotonia, intellectual disability, and motor deficit due to a mutation in the monocarboxylate transporter 8, which is a thyroid hormone transporter. A 6-month-old male patient presented to our outpatient clinic with a serious hypotonia complaint. With a preliminary diagnosis of AHDS, a molecular genetic examination was performed. The molecular genetic analysis detected a new previously unidentified variant in the SLC16A2 gene. This case has been presented to report the AHDS, which is a rare cause of hypotonia in patients presenting/consulting with severe hypotonia, global developmental delay, and abnormal thyroid function test results. Besides, a novel pathogenic mutation in the SLC16A2 gene has been described in the present article.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article